发明名称 |
METHODS AND COMPOSITIONS TO LOWER PLASMA CHOLESTEROL LEVELS |
摘要 |
A method is disclosed for determining whether a compound binds to a lipoprotein such as LDL or VLDL in a manner which will lower plasma cholesterol is provided that includes assessing the ability of the compound to form a complex with the lipoprotein, e.g., LDL or VLDL, and then determining whether the newly formed complex causes a change in the structure of apoB-100 that results in increased binding affinity to the LDL receptor. Also disclosed is a method for lowering cholesterol in a host in need thereof, including a human, is provided that includes the administration fo an effective amount of a compound which binds to cholesterol-carrying lipoprotein (e.g. LDL or VLDL) in a manner that alters the three dimensional configuration of the lipoprotein and increases the binding affinity of the apoB-100 protein to the LDL receptor, including those on the surface of a hepatic cell.
|
申请公布号 |
WO0028332(A9) |
申请公布日期 |
2000.09.28 |
申请号 |
WO1999US26519 |
申请日期 |
1999.11.09 |
申请人 |
ATHEROGENICS, INC.;MEDFORD, RUSSELL, M.;SAXENA, UDAY |
发明人 |
MEDFORD, RUSSELL, M.;SAXENA, UDAY |
分类号 |
A61K31/00;A61K31/10;A61K31/12;A61K31/165;A61K31/166;A61K31/18;A61K31/192;A61K31/20;A61K31/222;A61K31/225;A61K31/455;A61K31/7028;A61K31/785;A61K45/06;A61P3/06;A61P9/10;G01N27/447;G01N33/15;G01N33/50;G01N33/53;G01N33/566;G01N33/92;(IPC1-7):G01N33/92;G01N33/68 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|